← Leaderboards
Mario Ostrowski
Niaid Extramural Activities
$1,652,878
Attributed
$1,976,407
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $659.3K · FY2015–19$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,976,407 · 2
By mechanism
R61$1,329,349 · 1
R01$647,058 · 1
Top collaborators
- Rudolf Arnold Goetz Ehrhardt3 shared
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsCd4 Positive T LymphocytesCohortT-LymphocyteIn VivoCellsMemory Cd4 T LymphocyteLifeResearch ProposalsVirusProteinsModificationAntiviral TherapySuccessBiochemicalCell LineAntigensBerlinCell KillingCell ModelBaseCcr5 GeneCd4 AntigensAntigen Binding
Grant awards (7)
Harnessing the PIWI piRNA pathway to silence HIV$441,040
R61 · FY2019 · DA · contact PI
Harnessing the PIWI piRNA pathway to silence HIV$438,016
R61 · FY2018 · DA · contact PI
Harnessing the PIWI piRNA pathway to silence HIV$450,293
R61 · FY2017 · DA · contact PI
Discovery of novel surface biomarkers of latently HIV-infected cells using lamprey antibody technology$209,008
R01 · FY2017 · AI · contact PI
Discovery of novel surface biomarkers of latently HIV-infected cells using lamprey antibody technology$219,025
R01 · FY2016 · AI · contact PI
Discovery of novel surface biomarkers of latently HIV-infected cells using lamprey antibody technology$219,025
R01 · FY2015 · AI · contact PI
Role of CD4 T cell Help and CD40 Ligand in anti-HIV-1 Cytotoxic T cell Responses$0
Z01 · FY2000 · AI